Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

GlaxoSmithKline PLC (G1SK34)

B3
Currency in BRL
42.08
-0.20(-0.47%)
Closed

G1SK34 Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa8,0208,4417,9527,4036,768
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-4.76%+5.25%-5.79%-6.9%-8.58%
aa.aaaa.aaaa.aaaa.aaaa.aa4,6455,7494,38514,9564,928
aa.aaaa.aaaa.aaaa.aaaa.aa2,3342,0502,1221,9432,091
aa.aaaa.aaaa.aaaa.aaaa.aa---204203
aa.aaaa.aaaa.aaaa.aaaa.aa769-2751,121-8,342402
aa.aaaa.aaaa.aaaa.aaaa.aa272917324-1,358-856
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-5,3542,161-1,777-8,772-1,595
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
aa.aaaa.aaaa.aaaa.aaaa.aa-244.75%+140.36%-182.23%-393.64%+81.82%
aa.aaaa.aaaa.aaaa.aaaa.aa-1,265-989-950-1,143-1,314
aa.aaaa.aaaa.aaaa.aaaa.aa954913214628
aa.aaaa.aaaa.aaaa.aaaa.aa-3,684-120-114-3,187-1,468
aa.aaaa.aaaa.aaaa.aaaa.aa104117-17-4349
aa.aaaa.aaaa.aaaa.aaaa.aa-6043,104-828-4,5451,110
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-1,840-10,132-7,589823-5,641
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa+71.2%-450.65%+25.1%+110.84%-785.42%
aa.aaaa.aaaa.aaaa.aaaa.aa7,8893,2983012,046223
aa.aaaa.aaaa.aaaa.aaaa.aa3,095-3011,021-
aa.aaaa.aaaa.aaaa.aaaa.aa4,7943,298-1,025223
aa.aaaa.aaaa.aaaa.aaaa.aa-4,374-7,514-2,485-6,870-2,790
aa.aaaa.aaaa.aaaa.aaaa.aa-4,160-7,332-2,304-5,074-2,449
aa.aaaa.aaaa.aaaa.aaaa.aa-214-182-181-1,796-341
aa.aaaa.aaaa.aaaa.aaaa.aa5129212510
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-3,953-3,977-3,999-3,467-2,247
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-1,453-1,968-1,4279,089-837
aa.aaaa.aaaa.aaaa.aaaa.aa-82-39-29152-99
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa744431-1,443-394-567
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
aa.aaaa.aaaa.aaaa.aaaa.aa3,9635,8615,7174,1173,503
aa.aaaa.aaaa.aaaa.aaaa.aa4,7076,2924,2743,7232,936
aa.aaaa.aaaa.aaaa.aaaa.aa4,782.55,562.754,8474,949.383,562.13
aa.aaaa.aaaa.aaaa.aaaa.aa+283.79%+16.31%-12.87%+2.11%-28.03%
aa.aaaa.aaaa.aaaa.aaaa.aa---3.57%3.00%
* In Millions of GBP (except for per share items)